SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-009843
Filing Date
2019-08-02
Accepted
2019-08-02 13:37:11
Documents
103
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akorn10q-06302019.htm   iXBRL 10-Q 2187741
2 EXHIBIT 31.1 exhibit311-06302019.htm EX-31.1 9828
3 EXHIBIT 31.2 exhibit312-06302019.htm EX-31.2 9875
4 EXHIBIT 32.1 exhibit321-06302019.htm EX-32.1 5150
5 EXHIBIT 32.2 exhibit322-06302019.htm EX-32.2 4989
  Complete submission text file 0001628280-19-009843.txt   11684945

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akrx-20190630.xsd EX-101.SCH 79502
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akrx-20190630_cal.xml EX-101.CAL 131352
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akrx-20190630_def.xml EX-101.DEF 324278
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akrx-20190630_lab.xml EX-101.LAB 1008671
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akrx-20190630_pre.xml EX-101.PRE 592557
11 EXTRACTED XBRL INSTANCE DOCUMENT akorn10q-06302019_htm.xml XML 2423334
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32360 | Film No.: 19995283
SIC: 2834 Pharmaceutical Preparations